Photo from wikipedia
Serum neurofilament light chain (sNfL) is a promising biomarker of MS activity, progression, and treatment response. The aim of the present study was to address whether sNfL concentrations are affected… Click to show full abstract
Serum neurofilament light chain (sNfL) is a promising biomarker of MS activity, progression, and treatment response. The aim of the present study was to address whether sNfL concentrations are affected by supplementation of vitamin D and correlate with disease activity in interferon‐beta‐1b (IFNb‐1b)‐treated Finnish MS.
Keywords:
interferon beta;
serum neurofilament;
neurofilament light;
light chain
Journal Title: Brain and Behavior
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Brain and Behavior
Year Published: 2020
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!